BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31244822)

  • 21. Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A (H1N1) and swine-origin triple-reassortant H3N2 influenza viruses.
    Hillaire MLB; Vogelzang-van Trierum SE; Kreijtz JHCM; de Mutsert G; Fouchier RAM; Osterhaus ADME; Rimmelzwaan GF
    J Gen Virol; 2013 Mar; 94(Pt 3):583-592. PubMed ID: 23152369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition effects of novel polyketide compound PPQ-B against influenza A virus replication by interfering with the cellular EGFR pathway.
    Wang M; Wang S; Wang W; Wang Y; Wang H; Zhu W
    Antiviral Res; 2017 Jul; 143():74-84. PubMed ID: 28414053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations flanking the carbohydrate binding site of surfactant protein D confer antiviral activity for pandemic influenza A viruses.
    Nikolaidis NM; White MR; Allen K; Tripathi S; Qi L; McDonald B; Taubenberger J; Seaton BA; McCormack FX; Crouch EC; Hartshorn KL
    Am J Physiol Lung Cell Mol Physiol; 2014 Jun; 306(11):L1036-44. PubMed ID: 24705721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiviral activity of chlorogenic acid against influenza A (H1N1/H3N2) virus and its inhibition of neuraminidase.
    Ding Y; Cao Z; Cao L; Ding G; Wang Z; Xiao W
    Sci Rep; 2017 Apr; 7():45723. PubMed ID: 28393840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic characterization of circulating seasonal Influenza A viruses (2005-2009) revealed introduction of oseltamivir resistant H1N1 strains during 2009 in eastern India.
    Agrawal AS; Sarkar M; Ghosh S; Roy T; Chakrabarti S; Lal R; Mishra AC; Chadha MS; Chawla-Sarkar M
    Infect Genet Evol; 2010 Dec; 10(8):1188-98. PubMed ID: 20678590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative efficacy paradigms of the influenza clinical drug candidate EIDD-2801 in the ferret model.
    Toots M; Yoon JJ; Hart M; Natchus MG; Painter GR; Plemper RK
    Transl Res; 2020 Apr; 218():16-28. PubMed ID: 31945316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immune protective effectiveness of seasonal influenza spilt vaccine against homologous and heterogonous subtypes of influenza virus in mice].
    Huang BY; Wang XP; Wang WL; Hu W; Gao Q; Tan WJ; Ruan L
    Bing Du Xue Bao; 2011 May; 27(3):265-73. PubMed ID: 21774253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral and anti-inflammatory activity of arbidol hydrochloride in influenza A (H1N1) virus infection.
    Liu Q; Xiong HR; Lu L; Liu YY; Luo F; Hou W; Yang ZQ
    Acta Pharmacol Sin; 2013 Aug; 34(8):1075-83. PubMed ID: 23770981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.
    Ikematsu H; Kawai N
    Expert Rev Anti Infect Ther; 2011 Oct; 9(10):851-7. PubMed ID: 21973296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase.
    Ding Y; Dou J; Teng Z; Yu J; Wang T; Lu N; Wang H; Zhou C
    Arch Virol; 2014 Dec; 159(12):3269-78. PubMed ID: 25078390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-Clinical Evaluation of the Antiviral Activity of Epigalocatechin-3-Gallate, a Component of Green Tea, against Influenza A(H1N1)pdm Viruses.
    Stannard H; Koszalka P; Deshpande N; Desjardins Y; Baz M
    Viruses; 2023 Dec; 15(12):. PubMed ID: 38140688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An I436N substitution confers resistance of influenza A(H1N1)pdm09 viruses to multiple neuraminidase inhibitors without affecting viral fitness.
    Kwon JJ; Choi WS; Jeong JH; Kim EH; Lee OJ; Yoon SW; Hwang J; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
    J Gen Virol; 2018 Mar; 99(3):292-302. PubMed ID: 29493493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies Against Egg- and Cell-Grown Influenza A(H3N2) Viruses in Adults Hospitalized During the 2017-2018 Influenza Season.
    Levine MZ; Martin ET; Petrie JG; Lauring AS; Holiday C; Jefferson S; Fitzsimmons WJ; Johnson E; Ferdinands JM; Monto AS
    J Infect Dis; 2019 May; 219(12):1904-1912. PubMed ID: 30721982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
    Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral resistance due to deletion in the neuraminidase gene and defective interfering-like viral polymerase basic 2 RNA of influenza A virus subtype H3N2.
    Trebbien R; Christiansen CB; Fischer TK
    J Clin Virol; 2018 May; 102():1-6. PubMed ID: 29448067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiviral activity of a synthesized shikonin ester against influenza A (H1N1) virus and insights into its mechanism.
    Zhang Y; Han H; Qiu H; Lin H; Yu L; Zhu W; Qi J; Yang R; Pang Y; Wang X; Lu G; Yang Y
    Biomed Pharmacother; 2017 Sep; 93():636-645. PubMed ID: 28688289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility of influenza viruses to hypothiocyanite and hypoiodite produced by lactoperoxidase in a cell-free system.
    Patel U; Gingerich A; Widman L; Sarr D; Tripp RA; Rada B
    PLoS One; 2018; 13(7):e0199167. PubMed ID: 30044776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral effect of a derivative of isonicotinic acid enisamium iodide (FAV00A) against influenza virus.
    Cocking D; Cinatl J; Boltz DA; Peng X; Johnson W; Muzzio M; Syarkevych O; Kostyuk G; Goy A; Mueller L; Margitich VI
    Acta Virol; 2018; 62(2):191-195. PubMed ID: 29895160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro anti-influenza A activity of interferon (IFN)-λ1 combined with IFN-β or oseltamivir carboxylate.
    Ilyushina NA; Donnelly RP
    Antiviral Res; 2014 Nov; 111():112-20. PubMed ID: 25245230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-replication BM2SR vaccine provides sterilizing immunity and cross-lineage influenza B virus protection in mice.
    Moser MJ; Hatta Y; Gabaglia C; Sanchez A; Dias P; Sarawar S; Kawaoka Y; Hatta M; Neumann G; Bilsel P
    Vaccine; 2019 Jul; 37(32):4533-4542. PubMed ID: 31280945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.